东星医疗
(301290)
| 流通市值：22.37亿 | | | 总市值：28.16亿 |
| 流通股本：7957.85万 | | | 总股本：1.00亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 180,301,173.22 | 90,470,397.6 | 387,491,879.48 | 283,737,516.84 |
| 营业收入 | 180,301,173.22 | 90,470,397.6 | 387,491,879.48 | 283,737,516.84 |
| 二、营业总成本 | 160,558,195.68 | 76,752,373.59 | 337,268,334.44 | 245,520,282.82 |
| 营业成本 | 92,777,299.73 | 45,029,457.2 | 199,213,228.46 | 147,468,580.15 |
| 税金及附加 | 3,253,073.44 | 1,411,768.27 | 5,518,674.05 | 4,043,497.65 |
| 销售费用 | 22,016,112.73 | 9,625,118.58 | 46,367,017.81 | 33,791,434.11 |
| 管理费用 | 31,508,566.73 | 15,453,279.19 | 63,941,156.18 | 46,609,223.76 |
| 研发费用 | 9,755,048.36 | 4,574,302.29 | 20,971,465.7 | 13,107,931.23 |
| 财务费用 | 1,248,094.69 | 658,448.06 | 1,256,792.24 | 499,615.92 |
| 其中:利息费用 | 803,325.33 | 412,028.4 | 1,274,131.63 | 862,315.13 |
| 其中:利息收入 | 141,768.59 | 39,465.75 | 671,583.96 | 809,921.85 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 8,640,115.72 | 792,825.2 | 3,009,016.45 | 807,275.54 |
| 加:投资收益 | 10,443,499.47 | 6,619,692.18 | 25,124,609.35 | 18,893,562.47 |
| 资产处置收益 | 33,887.74 | - | -34,272.58 | -18,726.95 |
| 资产减值损失(新) | 22,687.11 | -45,484.26 | -107,992,256.77 | -103,633,640.88 |
| 信用减值损失(新) | 576,385.69 | -581,411.19 | 631,861.63 | 1,278,685.66 |
| 其他收益 | 1,317,615.04 | 975,636.4 | 2,598,224.25 | 1,921,865.18 |
| 四、营业利润 | 40,777,168.31 | 21,479,282.34 | -26,439,272.63 | -42,533,744.96 |
| 加:营业外收入 | 257,793.19 | 3,077.96 | 93,661.11 | 92,271.74 |
| 减:营业外支出 | 413,135.89 | 197,986.05 | 1,231,591.03 | 649,699.81 |
| 五、利润总额 | 40,621,825.61 | 21,284,374.25 | -27,577,202.55 | -43,091,173.03 |
| 减:所得税费用 | 7,326,768.52 | 3,767,621.29 | 12,318,597.47 | 10,430,618.76 |
| 六、净利润 | 33,295,057.09 | 17,516,752.96 | -39,895,800.02 | -53,521,791.79 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 33,295,057.09 | 17,516,752.96 | -39,895,800.02 | -53,521,791.79 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 34,136,935.52 | 17,916,413.08 | -37,940,258.51 | -53,201,637.49 |
| 少数股东损益 | -841,878.43 | -399,660.12 | -1,955,541.51 | -320,154.3 |
| 扣除非经常损益后的净利润 | 18,406,549.04 | 11,809,691.95 | -60,130,347.44 | -69,618,643.68 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.35 | 0.18 | -0.38 | -0.53 |
| (二)稀释每股收益 | 0.35 | 0.18 | -0.38 | -0.53 |
| 九、综合收益总额 | 33,295,057.09 | 17,516,752.96 | -39,895,800.02 | -53,521,791.79 |
| 归属于母公司股东的综合收益总额 | 34,136,935.52 | 17,916,413.08 | -37,940,258.51 | -53,201,637.49 |
| 归属于少数股东的综合收益总额 | -841,878.43 | -399,660.12 | -1,955,541.51 | -320,154.3 |
| 公告日期 | 2026-08-24 | 2026-04-21 | 2026-04-21 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |